Jan 27, 2022 / 12:00AM GMT
Operator
Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Conference Call. (Operator Instructions) Please be advised that today's call is being recorded. I'd now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.
Eric Hyllengren - Atara Biotherapeutics, Inc. - VP of IR & Finance
Thank you, operator. Good afternoon, everyone, and welcome to Atara's strategic Manufacturing Partnership Conference Call. Earlier today, we issued a press release announcing that we entered into a strategic manufacturing partnership with Fujifilm. This is an exciting partnership for both Atara and Fujifilm, and the press release and slides are available in the Investors & Media section at atarabio.com.
On today's call, we will provide an overview of the partnership, including the strategic rationale, as well as additional details of the transaction. Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive Officer; Dr.
Atara Biotherapeutics Inc T-Cell Operations and Manufacturing (ATOM) Facility Acquisition by FUJIFILM Diosynth Biotechnologies (FDB) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot